Machine intelligence decrypts β-lapachone as an allosteric 5-lipoxygenase inhibitor

Area of Science:

• Pharmacology and Computational Biology

Background:

• The anticancer activity of β-lapachone is not fully understood.
• Identifying specific molecular targets is crucial for drug development.

Purpose of the Study:

• To identify molecular targets of β-lapachone using machine learning.
• To validate β-lapachone as a modulator of 5-lipoxygenase (5-LO).
• To investigate the role of 5-LO inhibition in the anticancer effects of β-lapachone.

Main Methods:

• Machine learning algorithms were employed to predict potential targets of β-lapachone.
• Biochemical assays were conducted to validate the interaction between β-lapachone and 5-LO.
• The functional consequence of 5-LO modulation on cancer cells was assessed.

Main Results:

• Machine learning successfully identified potential targets for β-lapachone.
• β-lapachone was confirmed as a potent, ligand-efficient, allosteric, and reversible modulator of 5-LO.
• Inhibition of 5-LO by β-lapachone was shown to be a key mechanism underlying its anticancer activity.

Conclusions:

• This study highlights the utility of machine intelligence in target identification and systems pharmacology.
• β-lapachone's anticancer effects are mediated, in part, by the modulation of 5-LO.
• The findings provide a rationale for targeting 5-LO in cancer therapy.